New England Journal of Medicine
*Public Sector Research Institutions
*Stevenson-Wydler Technology Innovation Act of 1980 along with Bayh/Dole Act
the IT portion of drug development-probable neurotech as well
broader explaination of patent ownership
“The Neurotechnology Industry 2012 Report”
Neurotech tends to get little reporting. I suspect all the problems with the SSRIs. Approx. 12
percent of the market in mental health.
How would one judge “overperscription of neural stimulation” ?
“An Early – and Necessary – Flight of the Owl of Minerva: Neuroscience, Neurotechnology, Human Socio-cultural Boundaries, and the Importance of Neuroethics”
“Rapid neuroscientific advancement over the past 20 years has led to increased ethical, legal and social issues that are not confined to the academic world, but also are part of public discourse. There are questions on the use of neuroscientific techniques and novel neurotechnologies that are generated as we learn more about the brain and its relations to consciousness, emotion, behavior and the nature of self and relation to others. Should neuroscience and neurotechnology be used to advance humanity; or will it be engaged as demiurge and ultimately push humanity towards some new, and perhaps unanticipated reality?”